| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9328414 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
Menopausal women with estrogen receptor-positive breast cancer appear to have high risk of baseline subclinical endometrial abnormalities; therefore, an endometrial assessment, before the start of tamoxifen therapy, is always recommended in such patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Giancarlo Garuti, Fulvia Cellani, Giovanna Centinaio, Giulia Sita, Giulio Nalli, Massimo Luerti,